Menu

• Ask a Health Expert about BLOOD FIBRINOGEN INCREASED
• Post Your Side Effect related to BLOOD FIBRINOGEN INCREASED
• BLOOD FIBRINOGEN INCREASED and FDA Warnings
• BLOOD FIBRINOGEN INCREASED in Patients Wiki
• Report BLOOD FIBRINOGEN INCREASED in Drug Side Effect Survey

BLOOD FIBRINOGEN INCREASED side effect

What is BLOOD FIBRINOGEN INCREASED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Tysabri Side Effects Report #5639955-6
Consumer or non-health professional from GERMANY reported TYSABRI problem on Feb 12, 2008. Female patient, 30 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, immune system disorder, opportunistic infection, pneumonia, staphylococcal sepsis, urge incontinence, . TYSABRI dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5578214-7
VIDAZA problem was reported by a Physician from UNITED KINGDOM on Dec 19, 2007. Male patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, platelet count decreased, pulmonary embolism, . VIDAZA dosage: 156 MG, DAILY X 7 DAYS, SUBCUTANEOUS. During the same period patient was treated with ATENOLOL, FOLIC ACID, PYRIDOXINE, BENDOFLUMETHIAZIDE, FLUOXETINE, TRAMADOL, MESALAMINE, RANITIDINE. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5506239-6
Physician from JAPAN reported TEMODAL problem on Oct 25, 2007. Male patient, 53 years of age, weighting 125.7 lb, was diagnosed with anaplastic astrocytoma, recurrent cancer and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, deep vein thrombosis, dehydration, fibrin degradation products increased, intracranial tumour haemorrhage, neoplasm progression, pneumonia, . TEMODAL dosage: 150 MG/M2; QD; PO. During the same period patient was treated with SELBEX, LEXIN, SELENICA, PROTECADIN, MAGNESIUM OXIDE, RINDERON. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5534154-0
VIDAZA problem was reported by a Physician from UNITED KINGDOM on Nov 15, 2007. Male patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, international normalised ratio decreased, pulmonary embolism, . VIDAZA dosage: (156 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with ATENOLOL, FOLIC ACID, PYRIDOXINE, BENDROFLUMETHIAZIDE, FLUOXETINE, TRAMADOL, MESALAMINE, RANITIDINE. Patient was hospitalized. Patient recovered.


Augmentin Side Effects Report #5402688-5
Consumer or non-health professional from FRANCE reported AUGMENTIN problem on July 25, 2007. Male patient, 29 years of age, was diagnosed with postoperative care and was treated with AUGMENTIN. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, cyanosis, hyperhidrosis, hyperthermia, neutrophil count increased, obstructive airways disorder, sepsis, tachycardia, . AUGMENTIN dosage: unknown. During the same period patient was treated with TOPALGIC, DEPAKENE, LOXAPAC, CLOZAPINE, RISPERDAL, NORSET, PARKINANE, SCOPODERM. Patient was hospitalized. Patient died on 11/22/2006.

Argatroban Side Effects Report #5422308-3
ARGATROBAN problem was reported by a Health Professional from JAPAN on Aug 02, 2007. Male patient, 71 years of age, was diagnosed with cerebral thrombosis and was treated with ARGATROBAN. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, deep vein thrombosis, hepatic function abnormal, liver disorder, pneumonia aspiration, restlessness, . ARGATROBAN dosage: 60 MG, BID, INTRAVENOUS. During the same period patient was treated with RADICUT, GRTPA, ISOSORBIDE DINITRATE, LOW MOLECULAR DEXTRAN, FAMOTIDINE, ASPIRINA BAYER, LANSOPRAZOLE. Patient recovered.

Cypher Side Effects Report #5402375-3
Pharmacist from UNITED STATES reported CYPHER STENT problem on July 30, 2007. Male patient, 73 years of age, weighting 185.0 lb, was diagnosed with angina pectoris and was treated with CYPHER STENT. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, chills, fibrin d dimer increased, leukopenia, pyrexia, rash, thrombocytopenia, . CYPHER STENT dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

Cypher Side Effects Report #5402375-3
CYPHER STENT problem was reported by a Pharmacist from UNITED STATES on July 30, 2007. Male patient, 73 years of age, weighting 185.0 lb, was diagnosed with angina pectoris and was treated with CYPHER STENT. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, chills, fibrin d dimer increased, leukopenia, pyrexia, rash, thrombocytopenia, . CYPHER STENT dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

Menotrophin Side Effects Report #5736765-6
Consumer or non-health professional from FRANCE reported MENOTROPHIN problem on Apr 25, 2008. Female patient, 30 years of age, was diagnosed with in vitro fertilisation and was treated with MENOTROPHIN. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, escherichia infection, inflammation, peritonitis, pulmonary embolism, thrombocythaemia, . MENOTROPHIN dosage: unknown. During the same period patient was treated with CHORIONIC GONADOTROPIN. Patient was hospitalized. Patient recovered.


Temodal Side Effects Report #5753012-X
TEMODAL problem was reported by a Physician from JAPAN on May 21, 2008. Male patient, 53 years of age, weighting 125.7 lb, was diagnosed with anaplastic astrocytoma, neoplasm recurrence and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, deep vein thrombosis, dehydration, fibrin degradation products increased, pneumonia, tumour haemorrhage, . TEMODAL dosage: 150 MG/M2;QD;PO. During the same period patient was treated with SELBEX, LEXIN, SELENICA, PROTECADIN, MAGNESIUM OXIDE, RINDERON. Patient was hospitalized. Patient died on 06/12/2007.

Tysabri Side Effects Report #5718757-6
Consumer or non-health professional from GERMANY reported TYSABRI problem on Apr 09, 2008. Female patient, 30 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, immune system disorder, infection susceptibility increased, opportunistic infection, pneumonia, staphylococcal sepsis, urge incontinence, . TYSABRI dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.

Tamoxifen Side Effects Report #5347269-7
TAMOXIFEN CITRATE problem was reported by a Physician from ITALY on May 30, 2007. Female patient, 73 years of age, weighting 253.5 lb, was diagnosed with breast cancer and was treated with TAMOXIFEN CITRATE. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, bundle branch block left, diabetes mellitus, dyspnoea, fibrin d dimer increased, oedema peripheral, pulmonary embolism, tachycardia, . TAMOXIFEN CITRATE dosage: unknown. Patient was hospitalized. Patient recovered.

Augmentin Side Effects Report #5254282-7
Consumer or non-health professional from FRANCE reported AUGMENTIN problem on Feb 21, 2007. Male patient, 30 years of age, was diagnosed with postoperative care and was treated with AUGMENTIN. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, cyanosis, hyperhidrosis, hyperthermia, neutrophil count increased, obstructive airways disorder, tachycardia, . AUGMENTIN dosage: unknown. During the same period patient was treated with TOPALGIC, DEPAKENE, LOXAPAC, CLOZAPINE, RISPERDAL, NORSET, PARKINANE, SCOPODERM. Patient was hospitalized. Patient died on 11/22/2006.

Risperdal Side Effects Report #5258339-6
RISPERDAL problem was reported by a Health Professional from FRANCE on Mar 06, 2007. Male patient, 30 years of age, was diagnosed with schizophrenia, postoperative care and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, blood pressure decreased, cyanosis, hyperhidrosis, neutrophilia, obstructive airways disorder, pyrexia, respiratory tract congestion, self injurious behaviour, . RISPERDAL dosage: unknown. During the same period patient was treated with TRAMADOL, LOXAPAC, CLOZAPINE PANPHARMA, DEPAKENE, AUGMENTIN, PARKINANE LP, SCOPODERM TTS, SEGLOR. Patient died on 11/22/2006.


Depakene Side Effects Report #5282013-3
Health Professional from FRANCE reported DEPAKENE problem on Mar 23, 2007. Male patient, 79 years of age, was diagnosed with convulsion and was treated with DEPAKENE. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, coagulation factor vii level decreased, prothrombin level decreased, prothrombin time shortened, thrombocytopenia, . DEPAKENE dosage: unknown. Patient was hospitalized. Patient recovered.

Tysabri Side Effects Report #5670153-6
TYSABRI problem was reported by a Physician from GERMANY on Feb 28, 2008. Male patient, 45 years of age, weighting 191.8 lb, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood fibrinogen increased, mean cell haemoglobin increased, peritonsillar abscess, red blood cell count decreased, tonsillitis, . TYSABRI dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5683532-8
Physician from FRANCE reported VELCADE problem on Mar 17, 2008. Female patient, 54 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: asthenia, blood fibrinogen increased, breath sounds abnormal, chest pain, condition aggravated, cough, cytolytic hepatitis, dyspnoea, ear, nose and throat examination abnormal, . VELCADE dosage: unknown. During the same period patient was treated with MELPHALAN, PROPRANOLOL, VALACYCLOVIR, PREVISCAN, PAROXETINE, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Effexor Side Effects Report #5688487-8
EFFEXOR problem was reported by a Physician from FRANCE on Mar 25, 2008. Male patient, weighting 143.3 lb, was diagnosed with depression, mesothelioma and was treated with EFFEXOR. After drug was administered, patient experienced the following problems/side effects: anti-platelet antibody positive, blood fibrinogen increased, eosinophil count decreased, fibrin d dimer increased, haemoglobin decreased, haptoglobin increased, lymphocyte count decreased, thrombocytopenia, . EFFEXOR dosage: unknown. During the same period patient was treated with FOLIC ACID, CYANOCOBALAMIN, CISPLATIN, ALIMTA. Patient was hospitalized. Patient recovered.

Trileptal Side Effects Report #5592839-4
Consumer or non-health professional from FRANCE reported TRILEPTAL problem on Jan 08, 2008. Male patient, 80 years of age, was diagnosed with epilepsy, hypertension and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood fibrinogen increased, bradycardia, bundle branch block right, c-reactive protein increased, dyspnoea, electrocardiogram repolarisation abnormality, fibrin d dimer increased, hypotension, . TRILEPTAL dosage: 300 MG, BID. During the same period patient was treated with ACUITEL, TENORMIN, SELEGILINE, LASIX. Patient was hospitalized. Patient recovered.


Efalizumab Side Effects Report #5535571-5
EFALIZUMAB problem was reported by a Physician from SWITZERLAND on Nov 30, 2007. Female patient was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood fibrinogen increased, . EFALIZUMAB dosage: 0.8 ML, 1/WEEK. Patient recovered.

Tarceva Side Effects Report #5536557-7
Physician from ITALY reported TARCEVA problem on Nov 19, 2007. Female patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood fibrinogen increased, blood lactate dehydrogenase increased, blood ph increased, cyanosis, dyspnoea, fatigue, fibrin d dimer increased, haemoglobin decreased, . TARCEVA dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient recovered.

Arixtra Side Effects Report #5537417-8
ARIXTRA problem was reported by a Consumer or non-health professional from FRANCE on Nov 28, 2007. Female patient, 55 years of age, was diagnosed with deep vein thrombosis and was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood fibrinogen increased, deep vein thrombosis, haematoma, . ARIXTRA dosage: 2.5MG PER DAY. During the same period patient was treated with ZESTORETIC, SPECIAFOLDINE, NEXEN, TARDYFERON, MORPHINE, PERFALGAN. Patient was hospitalized. Patient recovered.

Arixtra Side Effects Report #5557624-8
Consumer or non-health professional from FRANCE reported ARIXTRA problem on Dec 06, 2007. Female patient, 55 years of age, weighting 149.9 lb, was diagnosed with deep vein thrombosis and was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood fibrinogen increased, deep vein thrombosis, haematoma, . ARIXTRA dosage: 2.5MG PER DAY. During the same period patient was treated with ZESTORETIC, SPECIAFOLDINE, NEXEN, TARDYFERON, MORPHINE, PERFALGAN. Patient was hospitalized. Patient recovered.

Taxotere Side Effects Report #5570312-7
TAXOTERE problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 19, 2007. Male patient, 60 years of age, weighting 127.8 lb, was diagnosed with neoplasm malignant and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood fibrinogen increased, faeces discoloured, international normalised ratio increased, melaena, platelet count increased, prothrombin time prolonged, . TAXOTERE dosage: 76.5 MG IV Q 21 DAYS. During the same period patient was treated with OXALIPLATIN, ATELONOLOL, DEXAMETHASONE, FILGRASTIM, HYDROCODONE BITARTRATE, NIRTOGLYCERINE, ENSURE, ONDANSETRON. Patient was hospitalized. Patient recovered.

Sulfasalazine Side Effects Report #5528516-5
Health Professional from FRANCE reported SULFASALAZINE problem on Nov 14, 2007. Male patient, 57 years of age, was diagnosed with colitis ulcerative and was treated with SULFASALAZINE. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood fibrinogen increased, c-reactive protein increased, colitis ulcerative, condition aggravated, cough, fatigue, hyperhidrosis, malaise, . SULFASALAZINE dosage: unknown. Patient was hospitalized. Patient recovered.

Prednisolone Side Effects Report #5710327-9
PREDNISOLONE problem was reported by a Consumer or non-health professional from JAPAN on Mar 28, 2008. Male patient, 21 years of age, weighting 141.1 lb, was treated with PREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood fibrinogen increased, coagulopathy, dilatation ventricular, disease complication, glomerulonephritis minimal lesion, intestinal congestion, lymphocyte percentage decreased, neutrophil percentage increased, . PREDNISOLONE dosage: 1 MG/KG /D IV. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient died.

Diclofenac Side Effects Report #5371863-0
Consumer or non-health professional from UNITED KINGDOM reported DICLOFENAC problem on June 15, 2007. Male patient, 44 years of age, was diagnosed with gout and was treated with DICLOFENAC. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, blood fibrinogen increased, blood pressure decreased, fibrin d dimer increased, laboratory test abnormal, respiratory rate increased, . DICLOFENAC dosage: 75 MG;BID;PO. Patient recovered.

Mylotarg Side Effects Report #5283730-1
MYLOTARG problem was reported by a Physician from JAPAN on Mar 23, 2007. Male patient, weighting 169.8 lb, was diagnosed with acute myeloid leukaemia, prophylaxis, insomnia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, blood fibrinogen increased, blood lactate dehydrogenase increased, blood pressure diastolic increased, c-reactive protein increased, condition aggravated, fibrin degradation products increased, nausea, . MYLOTARG dosage: unknown. During the same period patient was treated with GASTER, PRORENAL, ACLARUBICIN HYDROCHLORIDE, MUCOSTA, ZOLPIDEM TARTRATE, CYTARABINE, ETODOLAC, BAKTAR. Patient recovered.

Lovenox Side Effects Report #5306903-8
Consumer or non-health professional from reported LOVENOX problem on Apr 16, 2007. Male patient, 78 years of age, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: anaemia, blood fibrinogen increased, blood sodium decreased, cardiac failure, coagulation time prolonged, haematoma, haemodialysis, hyperkalaemia, . LOVENOX dosage: unknown. During the same period patient was treated with PREVISCAN, AUGMENTIN, ALLOPURINOL, LASILIX, DIGITALINE NATIVELLE, OROCAL D, BRICANYL, ATROVENT. Patient recovered.

Novantrone Side Effects Report #5270439-3
NOVANTRONE problem was reported by a Consumer or non-health professional from JAPAN on Mar 05, 2007. Female patient, 20 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: anorexia, blood fibrinogen increased, cardiotoxicity, cystitis haemorrhagic, electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, fungal sepsis, hepatic function abnormal, . NOVANTRONE dosage: unknown. During the same period patient was treated with MYLOTARG, CYTARABINE, ETOPOSIDE, HYDROCORTISONE SUCCINATE, ITRACONAZOLE, BACTRIM. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5649427-0
Physician from BELGIUM reported SORAFENIB problem on Feb 29, 2008. Female patient, 62 years of age, weighting 105.8 lb, was diagnosed with non-small cell lung cancer and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: anaemia, aplasia, blood fibrinogen increased, bone marrow failure, catheter related complication, condition aggravated, constipation, diarrhoea, electrolyte imbalance, . SORAFENIB dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Ambisome Side Effects Report #5673965-8
AMBISOME problem was reported by a Health Professional from ITALY on Feb 28, 2008. Male patient, 58 years of age, was diagnosed with myelofibrosis, graft versus host disease and was treated with AMBISOME. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, blood creatinine increased, blood fibrinogen increased, diarrhoea, fatigue, pancreatitis, peritoneal effusion, thrombocytopenic purpura, . AMBISOME dosage: 3 MG/KG, 3XWEEKLY, IV NOS; 7 MG/KG, WEEKLY, IV NOS. During the same period patient was treated with CYCLOSPORINE, ATENOLOL, ACYCLOVIR, BACTRIM DS, OMEPRAZOLE, ASPIRIN, FOLIC ACID. Patient was hospitalized. Patient recovered.

Citalopram Side Effects Report #5587155-0
Health Professional from ITALY reported CITALOPRAM HYDROBROMIDE problem on Dec 22, 2007. Male patient, 78 years of age, weighting 163.1 lb, was diagnosed with depression and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood creatine increased, blood fibrinogen increased, epistaxis, haematocrit decreased, haemoglobin decreased, international normalised ratio decreased, lymphocyte count decreased, mean cell volume decreased, . CITALOPRAM HYDROBROMIDE dosage: 10 MG QD PO. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, MONOKET, CARDIOASPIRIN, ESOPRAL, FINASTID, ITRIN. Patient was hospitalized. Patient recovered.

Temozolomide Side Effects Report #5564333-8
TEMOZOLOMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 14, 2007. Male patient, weighting 206.4 lb, was treated with TEMOZOLOMIDE. After drug was administered, patient experienced the following problems/side effects: anaemia, aspiration, blood fibrinogen increased, epistaxis, fibrin d dimer increased, haemoglobin decreased, haemoptysis, pulmonary embolism, pulmonary haemorrhage, . TEMOZOLOMIDE dosage: 4950 MG. During the same period patient was treated with BACTRIM, VALACYCLOVIR. Patient was hospitalized. Patient recovered.

Cisplatin Side Effects Report #5381894-2
Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on July 06, 2007. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer, bone disorder and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood calcium decreased, blood fibrinogen increased, blood potassium decreased, blood pressure decreased, blood sodium decreased, dehydration, diarrhoea, dyspnoea, . CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE, DURAGESIC, METAMIZOLE, OMEPRAZOLE, FORTECORTIN, DUPHALAC. Patient was hospitalized. Patient died on 06/16/2007.

Menotropins Side Effects Report #5392790-9
MENOTROPINS problem was reported by a Consumer or non-health professional from JAPAN on July 04, 2007. Female patient, 29 years of age, was treated with MENOTROPINS. After drug was administered, patient experienced the following problems/side effects: abdominal distension, ascites, blood fibrinogen increased, chest discomfort, haematocrit increased, haemoconcentration, haemoglobin increased, laboratory test abnormal, . MENOTROPINS dosage: unknown. During the same period patient was treated with CHORIONIC GONADTROPIN. Patient was hospitalized. Patient recovered.

Cisplatin Side Effects Report #5381894-2
Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on July 06, 2007. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer, bone disorder and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood calcium decreased, blood fibrinogen increased, blood potassium decreased, blood pressure decreased, blood sodium decreased, dehydration, diarrhoea, dyspnoea, . CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE, DURAGESIC, METAMIZOLE, OMEPRAZOLE, FORTECORTIN, DUPHALAC. Patient was hospitalized. Patient died on 06/16/2007.

Menotropins Side Effects Report #5392790-9
MENOTROPINS problem was reported by a Consumer or non-health professional from JAPAN on July 04, 2007. Female patient, 29 years of age, was treated with MENOTROPINS. After drug was administered, patient experienced the following problems/side effects: abdominal distension, ascites, blood fibrinogen increased, chest discomfort, haematocrit increased, haemoconcentration, haemoglobin increased, laboratory test abnormal, . MENOTROPINS dosage: unknown. During the same period patient was treated with CHORIONIC GONADTROPIN. Patient was hospitalized. Patient recovered.

Lamictal Side Effects Report #5711353-6
Physician from FRANCE reported LAMICTAL problem on Apr 09, 2008. Female patient, 18 years of age, weighting 79.37 lb, was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody positive, arthralgia, blood fibrinogen increased, c-reactive protein increased, chest pain, dysphagia, gait disturbance, infection, . LAMICTAL dosage: unknown. Patient was hospitalized. Patient recovered.

Bufferin Side Effects Report #5264699-2
BUFFERIN problem was reported by a Consumer or non-health professional from JAPAN on Mar 06, 2007. Female patient, 26 years of age, weighting 119.0 lb, was diagnosed with systemic lupus erythematosus, lupus nephritis and was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood fibrinogen increased, blood lactate dehydrogenase increased, brain natriuretic peptide increased, cardiac failure congestive, cardiac murmur, dilatation ventricular, . BUFFERIN dosage: 81 MG/D. During the same period patient was treated with ONEALFA, LASIX, ZANTAC, SELBEX, PREDNISOLONE, NEORAL. Patient was hospitalized. Patient recovered.

Lovenox Side Effects Report #5272917-X
Consumer or non-health professional from UNITED STATES reported LOVENOX problem on Sept 20, 2006. Female patient, weighting 6.13 lb, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood fibrinogen increased, blood gases abnormal, blood potassium increased, blood urea increased, cerebral palsy, convulsion, . LOVENOX dosage: unknown. Patient recovered.

Mesalazine Side Effects Report #5284359-1
MESALAZINE problem was reported by a Consumer or non-health professional from CROATIA (local name: Hrvatska) on Mar 15, 2007. Male patient, 13 years of age, was diagnosed with crohn's disease and was treated with MESALAZINE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood fibrinogen increased, c-reactive protein increased, condition aggravated, erythema nodosum, gait disturbance, infective myositis, muscle swelling, . MESALAZINE dosage: 1500 MG QDAY. During the same period patient was treated with AZATHIOPRINE. Patient was hospitalized. Patient recovered.